159 related articles for article (PubMed ID: 12107117)
1. Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system.
Kay DG; Yue P; Hanna Z; Jothy S; Tremblay E; Jolicoeur P
Am J Pathol; 2002 Jul; 161(1):321-35. PubMed ID: 12107117
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.
Hanna Z; Priceputu E; Hu C; Vincent P; Jolicoeur P
Virology; 2006 Mar; 346(1):40-52. PubMed ID: 16310238
[TBL] [Abstract][Full Text] [Related]
3. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
[TBL] [Abstract][Full Text] [Related]
4. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
5. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice.
Hanna Z; Priceputu E; Kay DG; Poudrier J; Chrobak P; Jolicoeur P
Virology; 2004 Oct; 327(2):273-86. PubMed ID: 15351215
[TBL] [Abstract][Full Text] [Related]
6. Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.
Hanna Z; Priceputu E; Chrobak P; Hu C; Dugas V; Goupil M; Marquis M; de Repentigny L; Jolicoeur P
J Virol; 2009 Oct; 83(19):9743-58. PubMed ID: 19605470
[TBL] [Abstract][Full Text] [Related]
7. The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck.
Hanna Z; Weng X; Kay DG; Poudrier J; Lowell C; Jolicoeur P
J Virol; 2001 Oct; 75(19):9378-92. PubMed ID: 11533201
[TBL] [Abstract][Full Text] [Related]
8. Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia.
Rahim MM; Chrobak P; Hu C; Hanna Z; Jolicoeur P
J Virol; 2009 Nov; 83(22):11830-46. PubMed ID: 19740990
[TBL] [Abstract][Full Text] [Related]
9. Two sorting motifs, a ubiquitination motif and a tyrosine motif, are involved in HIV-1 and simian immunodeficiency virus Nef-mediated receptor endocytosis.
Cai CY; Zhang X; Sinko PJ; Burakoff SJ; Jin YJ
J Immunol; 2011 May; 186(10):5807-14. PubMed ID: 21482738
[TBL] [Abstract][Full Text] [Related]
10. HIV Nef expression favors the relative preservation of CD4+ T regulatory cells that retain some important suppressive functions.
Chrobak P; Afkhami S; Priceputu E; Poudrier J; Meunier C; Hanna Z; Sparwasser T; Jolicoeur P
J Immunol; 2014 Feb; 192(4):1681-92. PubMed ID: 24465014
[TBL] [Abstract][Full Text] [Related]
11. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.
Weng X; Priceputu E; Chrobak P; Poudrier J; Kay DG; Hanna Z; Mak TW; Jolicoeur P
J Virol; 2004 May; 78(10):5244-57. PubMed ID: 15113906
[TBL] [Abstract][Full Text] [Related]
13. Design and use of an inducibly activated human immunodeficiency virus type 1 Nef to study immune modulation.
Walk SF; Alexander M; Maier B; Hammarskjold ML; Rekosh DM; Ravichandran KS
J Virol; 2001 Jan; 75(2):834-43. PubMed ID: 11134296
[TBL] [Abstract][Full Text] [Related]
14. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef.
Kajiyama W; Kopp JB; Marinos NJ; Klotman PE; Dickie P
Kidney Int; 2000 Sep; 58(3):1148-59. PubMed ID: 10972678
[TBL] [Abstract][Full Text] [Related]
15. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice.
Hanna Z; Kay DG; Rebai N; Guimond A; Jothy S; Jolicoeur P
Cell; 1998 Oct; 95(2):163-75. PubMed ID: 9790524
[TBL] [Abstract][Full Text] [Related]
16. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef.
Keppler OT; Allespach I; Schüller L; Fenard D; Greene WC; Fackler OT
J Virol; 2005 Feb; 79(3):1655-65. PubMed ID: 15650191
[TBL] [Abstract][Full Text] [Related]
17. Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice.
Dickie P
AIDS Res Hum Retroviruses; 2000 May; 16(8):777-90. PubMed ID: 10826484
[TBL] [Abstract][Full Text] [Related]
18. Normal development and function but impaired memory phenotype of CD8⁺ T cells in transgenic mice expressing HIV-1 Nef in its natural target cells.
Ahmed Rahim MM; Chrobak P; Priceputu E; Hanna Z; Jolicoeur P
Virology; 2013 Apr; 438(2):84-97. PubMed ID: 23433958
[TBL] [Abstract][Full Text] [Related]
19. Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.
Choi J; Walker J; Boichuk S; Kirkiles-Smith N; Torpey N; Pober JS; Alexander L
J Virol; 2005 Jan; 79(1):264-76. PubMed ID: 15596822
[TBL] [Abstract][Full Text] [Related]
20. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open.
Foster JL; Anderson SJ; Frazier AL; Garcia JV
Virology; 1994 Jun; 201(2):373-9. PubMed ID: 8184546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
